Associated Papers
Dramatic Response to Pyrotinib and T-DM1 in HER2-Negative Metastatic Breast Cancer With 2 Activating HER2 Mutations.
Tian H et al.
The Oncologist, 2023
High Frequency of ERBB2 Activating Mutations in Invasive Lobular Breast Carcinoma with Pleomorphic Features.
Rosa-Rosa JM et al.
Cancers, 2019
Select a paper to view details